Non-Small Cell Lung Cancer (NSCLC) Screening
Hello, doctor.
I recently had a health check-up, and my tumor markers SCC, NSE, and CEA were all normal.
However, my Cyfra 21-1 level was 3.47, which is above the normal range, and I'm a bit concerned.
I don't smoke or drink, and I don't have any symptoms.
The health check included a chest digital tomosynthesis, which was normal.
Should I see a pulmonologist for further evaluation?
Xiang, 20~29 year old female. Ask Date: 2020/08/01
Dr. Yang Wenda reply Pulmonology
Hello: Currently, cancer markers are not used to diagnose lung cancer; they are only used to monitor the treatment response in patients who have already been diagnosed.
It is recommended that you check the CYFRA 21-1 marker again in six months.
Reply Date: 2020/08/01
More Info
Elevated levels of Cyfra 21-1, a tumor marker primarily associated with lung cancer, can understandably cause concern, especially when other tumor markers such as SCC, NSE, and CEA are normal. Cyfra 21-1 is a fragment of cytokeratin 19 and is often elevated in patients with non-small cell lung cancer (NSCLC), but it can also be elevated in other conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and even in smokers or those with a history of lung disease.
Given that your Cyfra 21-1 level is 3.47, which is above the normal range, it is important to consider the context of this elevation. The fact that you do not smoke or drink alcohol and have no significant symptoms is reassuring. Additionally, your recent chest CT scan being normal is a positive indicator. However, it is essential to remember that tumor markers are not definitive diagnostic tools; they are used in conjunction with clinical findings and imaging studies to assess the likelihood of malignancy.
In your case, it would be prudent to consult a pulmonologist, especially since you have an elevated Cyfra 21-1 level. A pulmonologist can perform a thorough evaluation, which may include a detailed history and physical examination, additional imaging studies, or even pulmonary function tests if necessary. They may also consider repeating the Cyfra 21-1 test after a certain period to see if the levels change, as transient elevations can occur due to benign conditions.
It's also worth noting that while elevated tumor markers can be concerning, they do not always indicate cancer. Many factors can influence these levels, and a comprehensive approach is necessary to determine the underlying cause. If the pulmonologist deems it necessary, they may recommend further investigations, such as a bronchoscopy or biopsy, if there are any suspicious findings.
In summary, while your elevated Cyfra 21-1 level warrants further investigation, the absence of symptoms and normal results from other tests are encouraging. Consulting a pulmonologist is a sensible step to ensure that any potential issues are addressed appropriately. They can provide you with a clearer understanding of your situation and guide you on the next steps, whether that involves monitoring, further testing, or reassurance based on your overall health status. Remember, early detection and intervention are key in managing any health concerns, so seeking expert advice is always a wise choice.
Similar Q&A
Understanding Elevated Cyfra21-1 Levels: When to Seek Further Medical Evaluation
Hello doctor, recently during the company health check, my Cyfra21-1 level was elevated at 5.9, whereas in previous years it was around 1.x. I have previously experienced chest tightness and pain, and I have visited three hospitals where I underwent X-rays, but no abnormalities w...
Dr. Wang Lanfeng reply Pulmonology
Hello: Cyfra21-1 is a tumor marker found in the blood, and its test values can be influenced by many factors, leading to a higher rate of false positives. Generally, tumor markers are used to monitor the condition of cancer patients after treatment and are not suitable for early ...[Read More] Understanding Elevated Cyfra21-1 Levels: When to Seek Further Medical Evaluation
Understanding CYFRA 21-1 Levels in Lung Cancer Screening
On March 18, during a health check, I underwent lung cancer screening with CYFRA 21-1 (normal range 0-3.3 ng/mL), and my result was exactly 3.3 ng/mL. I have a smoking habit. 1. Which specialist should I see? 2. What additional tests do I need to undergo? 3. Should I have a follo...
Dr. Zhou Ziguang reply Pulmonology
Hello: 1. You may first consult with the physician regarding the health check-up explanation. 2. If a chest examination is needed, you can visit a pulmonologist.[Read More] Understanding CYFRA 21-1 Levels in Lung Cancer Screening
Understanding Elevated Cypra21-1 Levels: When to Seek Chest Specialist Care
Hello Dr. Yang, Three years ago during my health check-up, my Cypra21-1 value was 3.4 (normal is less than 3.3). A month later, I had another blood test at the lab, and the results were normal, so I did not require any special follow-up. However, during my recent health check-up...
Dr. Yang Wenda reply Pulmonology
Hello: The Cypra21 value is expected to fluctuate. It is recommended to follow up every 3 to 6 months, along with X-ray examinations, and to have a thoracic specialist evaluate and provide recommendations.[Read More] Understanding Elevated Cypra21-1 Levels: When to Seek Chest Specialist Care
Understanding Abnormal Cell Keratin Antigen Levels in Pulmonary Health
I would like to ask the doctor, does an abnormal level of squamous cell carcinoma antigen indicate a lot?
Dr. Lu Mingzhi reply Pulmonology
Hello: The cytokeratin antigen you are referring to is likely CYFRA 21-1. Elevated levels of cytokeratin antigen 21-1 should raise the possibility of lung cancer and esophageal cancer, and tumors in other locations may also cause an increase in this marker. Non-tumor conditions s...[Read More] Understanding Abnormal Cell Keratin Antigen Levels in Pulmonary Health
Related FAQ
(Pulmonology)
Pulmonary Fibrosis(Pulmonology)
Respiratory Distress Syndrome(Pulmonology)
Ct Report(Pulmonology)
Health Examination Report(Pulmonology)
Covid-19(Pulmonology)
Ct Scan(Pulmonology)
Difficulty Breathing(Pulmonology)
Allergies(Pulmonology)
Lung Nodule(Pulmonology)